Julia Bonavitacola

Blood-based screening for colorectal cancer (CRC) should only be used with patients who are not completing other endorsed screening options, according to a study.

William R. Short, MD, MPH, of the University of Pennsylvania, discusses how a label update for bictegravir can help provide safe and effective HIV treatment for pregnant people.

A new definition of rectal cancer in the Netherlands prompted reclassification of cancer as sigmoid tumors, which could lead to better treatment.

Models that are code-free were able to perform as accurately as expert-designed bespoke models when classifying retinal pathologies.

Theodore R. Levin, MD, discusses new study he coauthored, which found that screening rates for colorectal cancer (CRC) increased across all demographics when using automated and personalized reminders.

Asian men who have sex with men (MSM) who recently immigrated to Australia were found to have lower uptake of pre-exposure prophylaxis (PrEP).

Test your knowledge of the April 2024 issue of AJMC with a quick quiz!

Polyglycolic acid (PGA) sheets could help reduce rates of anastomotic leakage, which is a leading cause of mortality in colorectal cancer surgeries.

Men who have sex with men (MSM) who are HIV-negative reported interest in an injectable pre-exposure prophylaxis (PrEP) that lasted longer than the daily pill, regardless of cost or coverage.

A new study found that dentists were lacking in experience when it came to dental aspects of HIV infection.

New data show that survival in patients living with postoperative colorectal cancer (CRC) could be predicted using a nomogram model.

Findings from a study with a limited sample size suggest that patching is both effective and does not impede development in children who patch for at least 120 minutes each day.

HIV testing uptake was improved in immigrants after peer interventions with multiple strategies were implemented.

Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.

Screening completion increased when using sequential automated and personalized strategies for colorectal cancer (CRC) in different demographic groups.

Poor mental health was worse in adults with strabismus compared with adults without strabismus.

Pregnant women with HIV need targeted interventions and improved care to combat these adverse outcomes.

Among patients who have survived colorectal cancer (CRC), there was an association between increased mortality due to CRC or cardiovascular disease and higher intake of ice cream and ultraprocessed foods.

HIV testing, treatment, and intervention session delivery were among some areas that saw challenges in properly addressing youth experiencing homelessness during an HIV prevention trial.

Digital technology being less accessible to adult patients with vision impairment (VI) could be a detriment to telemedicine accessibility.

Idecabtagene vicleucel (ide-cel) was able to triple progression-free survival and reduce the risk of disease progression or death in a phase 3 trial.

A new study found that tumor sites in stage I-III colorectal cancer (CRC) could affect recurrence-free survival and survival after recurrence in patients.

The subretinal drusenoid deposit form of age-related macular degeneration (AMD) was found to be associated with valvular heart disease as well as cardiac index.

A new study found that adults in custody of the Federal Bureau of Prisons have seen improved pre-exposure prophylaxis (PrEP) initiation and sustained treatment uptake for HIV.

A decrease in surgeries to address colorectal cancer (CRC) could lead to unknown consequences, including intensifying challenges faced by the patients.

Men who have sex with men (MSM) who primarily spoke Spanish and transgender women who spoke either English or Spanish had positive experiences with a mobile health (mHealth) intervention.

Adults with pulmonary arterial hypertension (PAH) have a new treatment available with the FDA approval of sotatercept (Winrevair; Merck), an activin signaling inhibitor biologic.

A real-world safety study found that patients treated with brolucizumab had low occurrences of intraocular inflammation, retinal vascular occlusion, and retinal vasculitis.

Older patients and patients of sub-Saharan African origin were at an increased risk of late presentation of advanced HIV.